Abstract:
BACKGROUND: Hypertensive disorders of pregnancy (HDP), including pre-eclampsia/eclampsia, account for significant maternal and fetal
mortality globally and especially in South Africa.
OBJECTIVE: To formulate clinical guidelines for the management of HDP in order to substantially reduce the number of maternal deaths
from HDP.
METHODS: The Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument was used to formulate the guidelines and
included six domains: scope and purpose; stakeholder involvement; rigour and development; clarity of presentation; applicability; and
editorial independence.
RECOMMENDATIONS: The guideline stipulates management strategies for all levels of care where women with hypertensive disorders in
pregnancy are seen. It also has a detailed implementation plan.
CONCLUSION: A clinical guideline that is of practical value has been formulated by a wide group of stakeholders. It is hoped that its
dissemination and implementation by all doctors and nurses will reduce mortality and morbidity associated with HDP.
